News
CRISPR Therapeutics Just Slashed Its Staff by 10%. Should Shareholders Be Worried?
As reported by Fierce Biotech on Nov. 22, gene-therapy star CRISPR Therapeutics (NASDAQ: CRSP) laid off 10% of its employees shortly after reporting its Q3 earnings earlier in the month. Given that
Why Viking Therapeutics Was Crushing It This Week
A multibillion-dollar deal in the healthcare industry helped lift the stock of a company, Viking Therapeutics (NASDAQ: VKTX), not directly involved in the transaction. The deal centered around a hot
3 High-Yielding Dividend Stocks That Are Near Their 52-Week Lows
Are you looking for some quality dividend stocks to buy right now? When it comes to investing, it's often a good idea to check out those that haven't been doing too well lately and are trading near
Could Regeneron Pharmaceuticals Stock Help You Become a Millionaire?
Regeneron Pharmaceuticals (NASDAQ: REGN) is a top pharmaceutical company with many promising assets in its portfolio. Its diverse business has enabled the business to grow over the years. In the
AbbVie's on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?
These days, it seems like biotech buyout offers are falling from the sky. During the week ended Dec. 6, AbbVie (NYSE: ABBV) announced not one but two big acquisitions.
The pharma giant's latest big
My Take: 4 Strong Growth Stocks to Buy This Week
Are you looking for new growth stocks for your portfolio? The idea was compelling a week ago when the market was roaring higher. Now, with fresh headwinds blowing, not so much.
Just bear in mind
Why Advanced Micro Devices Stock Popped Today
Shares of Advanced Micro Devices (NASDAQ: AMD) climbed 9.9% on Thursday after the chipmaker launched a line of new large accelerated processing units (APUs) designed to handle AI workloads that
Got $5,000? These 3 Stocks Are Deep-Value Buys Right Now
A $5,000 investment may not seem a significant amount to some, but it can generate tremendous returns in the long run. If you were to invest in the S&P 500, which averages an annual return of around
2 Reasons to Buy Nvidia Stock, and 1 Reason to Sell
In 2023, Nvidia (NASDAQ: NVDA) has had one of its best years in business since its founding over three decades ago. The company's business exploded after the launch of OpenAI's ChatGPT reignited
Is AbbVie Stock a Buy Now?
Leading healthcare company AbbVie (NYSE: ABBV) appears to be hungry for deals to help it diversify its revenue streams. That's because it will need to become less reliant on Humira, its blockbuster
Which Stock Is More Likely to Help You Retire as a Millionaire: AbbVie or Eli Lilly?
Many investors have flocked to big pharma stocks throughout the years. And doing so has paid off handsomely with several of those stocks.
AbbVie (NYSE: ABBV) and Eli Lilly (NYSE: LLY) stand out as
This Newly Discovered Risk Could Be a Big Headache for Vertex Pharmaceuticals and CRISPR Therapeutics
In the gene editing therapies space, there aren't any competitors being watched more closely than Vertex Pharmaceuticals (NASDAQ: VRTX) and CRISPR Therapeutics (NASDAQ: CRSP). The pair scored
Humana Announces $500K Investment in the Virginia Health Care Foundation to Boost Behavioral Health Workforce Development and Support
Leading health and well-being company Humana today announced a meaningful investment of $500,000 in the Virginia Health Care Foundation (VHCF). This funding will bolster crucial behavioral health
Dexcom G7, the Smallest, Most Accurate, Easy-to-Use CGM Now Connects to the Tandem t:slim X2 Insulin Pump
DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System now
If You Think Home Depot Stock Is Dead Money Now, You Might Be Blown Away by Its Eye-Popping Returns Over Time
Home Depot's (NYSE: HD) days of rapid growth are likely behind it. In recent years, it has added few locations as it has saturated its markets in the U.S. and Canada, and its previous plans to
5 Dividend Stocks That Recently Increased Their Payouts
My favorite stocks to invest in are those that continuously increase their dividend. Merck & Co (NYSE: MRK) is one stock that I like a lot that has been growing its dividend at a solid clip for a
EQS-News: Evotec-partner Jingxin receives approval for EVT201 in China
EQS-Adhoc: Merck KGaA: Phase III trial results for evobrutinib in relapsing multiple sclerosis did not meet primary endpoint of reducing annualized relapse rates (ARR) compared to oral teriflunomide
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius retains relief payments for hospitals of up to €300 million (from the current perspective) and is therefore subject to a ban on dividends and bonuses for 2023
Why AT&T Stock Is Up Today
AT&T (NYSE: T) is betting big on new open-source telecom equipment that it says will save it billions over time. Investors are excited about the development, sending AT&T shares up about 3% as of 11
A Bull Market Is Coming: 2 Top Stocks to Buy Hand Over Fist
Are we currently in a bull market? Some argue that we are. In early June, the S&P 500 closed 20% up from its most recent low, which is the technical definition of a bull market. However, equities
Humana Foundation Awards Health Equity Research Grants Equal to $1 Million to Three University Partners
The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 41 years, today announced the recipients of its first-ever research grants in service of the Foundation’s health
1 of Cathie Wood's Favorite Artificial Intelligence (AI) Stocks Is Skyrocketing. Is It a No-Brainer Buy Right Now?
This year might go down in the annals of investing as the year of artificial intelligence (AI) stocks. The explosion of interest in AI lit a fire beneath several stocks, including some of the
EQS-News: Gerresheimer AG: Guido Pickert to head up Investor Relations at Gerresheimer
